Biphasic insulin aspart vs Dapagliflozin
National NHS prescribing compared (Prescription Cost Analysis)
Dapagliflozin was dispensed 22.5× as often as Biphasic insulin aspart in March 2026 — 1,120,842 items versus 49,836 in England.
49,836items
Biphasic insulin aspart · March 2026
NHSBSA Prescription Cost Analysis
1,120,842items
Dapagliflozin · March 2026
NHSBSA Prescription Cost Analysis
Figure 1. Biphasic insulin aspart versus Dapagliflozin: national items dispensed by month
▬ Biphasic insulin aspart · ╌ Dapagliflozin
Source: NHSBSA Prescription Cost Analysis, to March 2026
| Measure | Biphasic insulin aspart | Dapagliflozin |
|---|---|---|
| Items, March 2026 | 49,836 | 1,120,842 |
| Items, last 12 months | 618,619 | 11,570,596 |
| Net ingredient cost, March 2026 | £2,365,581 | £8,162,552 |
See the full profile for Biphasic insulin aspart or Dapagliflozin.